Financing, Equity Capital Markets

Revance Therapeutics, Inc.

02/20
|
$250.0 Million
Piper Sandler served as co-manager for Revance Therapeutics, Inc. on a convertible offering
Sub-Type
Convertible Offering
Sub-Sector
Biopharma